Revenio Group Oyj

Major Shareholding Notification • Jan 30, 2018

Disclosure 357786

Revenio Group Oyj - Major shareholder announcements

Revenio Group Corporation: Notice pursuant to chapter 9, section 5 of the securities market act

Revenio Group Corporation, Stock Exchange Release, January 30, 2018 at 17.30 Notice pursuant to chapter 9, section 5 of the securities market act Revenio Group Corporation has today received a notification of change in holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act that Evli Pankki Oyj's share of the total number of shares and voting rights in Revenio Group Corporation has decreased to less than five per cent. Evli Pankki Oyj now holds 379.117 shares in Revenio Group Corporation, which is 4.75 per cent of the company's shares and voting rights. The total number of Revenio Group Corporation's shares recorded in the trade register is 7.979.406. Revenio Group Corporation Timo Hildén President and CEO For further information, please contact: CEO & President Timo Hildén Telephone: +358 40 580 4774 timo.hilden@revenio.fi www.revenio.fi www.ventica.fi DISTRIBUTION: Nasdaq Helsinki Financial Supervisory Authority (FIN-FSA) Principal media www.revenio.fi The Revenio Group in brief Revenio is a Finnish, globally operating health technology corporation whose worldwide success is based on a strongly patented intraocular pressure measurement technology. The Revenio Group consists of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy. The common denominators of Revenio's business operations include screening, follow-up and the global need to make cost savings through preventive health care. Revenio seeks vigorous growth in health technology. Revenio aims to develop even more efficient and easily adopted methods for the early-stage detection of diseases with significance for public health. The focus of Revenio's screening technology is on the early detection of glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these during the treatment process. In 2016, Revenio Group's net sales totaled MEUR 23,4, with its operating margin for continuing operations standing at 30,1%. Revenio Group Corporation is listed on Nasdaq Helsinki. []